WILLIAM H. RASTETTER

Insider Reports History

Location
San Diego, CA
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by WILLIAM H. RASTETTER:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NEUROCRINE BIOSCIENCES INC Director Common Stock 40.4K $6.13M $151.82 05 Nov 2025 Direct
FATE THERAPEUTICS INC Director Stock Option (Right to Buy) 55K $109K $2.73 29 May 2025 Direct
Regulus Therapeutics Inc. Director Common Stock 0 $0 $7.87 25 Jun 2025 By The Rastetter Family Trust
Dare Bioscience, Inc. Director Stock Option (right to buy) 4.5K 09 Jul 2025 Direct
NEUROCRINE BIOSCIENCES INC Director Non-Qualified Stock Option 0 $79.02 05 Nov 2025 Direct
NEUROCRINE BIOSCIENCES INC Director Restricted Stock Unit 0 22 May 2025 Direct
Regulus Therapeutics Inc. Director Stock Option 0 25 Jun 2025 By The Rastetter Family Trust

Insider Reports Filed by WILLIAM H. RASTETTER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NBIX NEUROCRINE BIOSCIENCES INC 05 Nov 2025 3 -$1.87M 4 Director 06 Nov 2025, 17:25
DARE Dare Bioscience, Inc. 09 Jul 2025 1 $0 4 Director 10 Jul 2025, 16:05
RGLS Regulus Therapeutics Inc. 25 Jun 2025 10 $0 4 Director 27 Jun 2025, 17:12
FATE FATE THERAPEUTICS INC 29 May 2025 1 $0 4 Director 30 May 2025, 16:09
NBIX NEUROCRINE BIOSCIENCES INC 21 May 2025 3 $0 4 Director 22 May 2025, 18:15
NBIX NEUROCRINE BIOSCIENCES INC 05 May 2025 3 -$2.02M 4 Director 07 May 2025, 19:05
RGLS Regulus Therapeutics Inc. 30 Apr 2025 1 $0 4 Director 30 Apr 2025, 16:30
NBIX NEUROCRINE BIOSCIENCES INC 15 Aug 2024 1 -$2.09M 4 Director 16 Aug 2024, 17:00
FATE FATE THERAPEUTICS INC 07 Jun 2024 1 $0 4 Director 11 Jun 2024, 16:35
DARE Dare Bioscience, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 17:15
NBIX NEUROCRINE BIOSCIENCES INC 22 May 2024 1 $0 4 Director 23 May 2024, 18:51
RGLS Regulus Therapeutics Inc. 20 May 2024 1 $0 4 Director 21 May 2024, 16:24
RGLS Regulus Therapeutics Inc. 16 May 2024 1 $0 4 Director 17 May 2024, 16:37
NBIX NEUROCRINE BIOSCIENCES INC 02 Jan 2024 3 -$1.45M 4 Director 04 Jan 2024, 18:26
RGLS Regulus Therapeutics Inc. 10 Aug 2023 1 $0 4 Director 14 Aug 2023, 17:31
DARE Dare Bioscience, Inc. 21 Jun 2023 1 $0 4 Director 21 Jun 2023, 21:39
RGLS Regulus Therapeutics Inc. 13 Jun 2023 1 $0 4 Director 13 Jun 2023, 16:53
FATE FATE THERAPEUTICS INC 06 Jun 2023 1 $0 4 Director 07 Jun 2023, 16:13
NBIX NEUROCRINE BIOSCIENCES INC 17 May 2023 1 $0 4 Director 19 May 2023, 17:21
NBIX NEUROCRINE BIOSCIENCES INC 01 May 2023 3 -$436K 4 Director 03 May 2023, 17:34
NBIX NEUROCRINE BIOSCIENCES INC 19 Apr 2023 6 -$729K 4 Director 21 Apr 2023, 18:58
DARE Dare Bioscience, Inc. 23 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:52
FATE FATE THERAPEUTICS INC 09 Jun 2022 2 $0 4 Director 13 Jun 2022, 16:43
RGLS Regulus Therapeutics Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:17
NBIX NEUROCRINE BIOSCIENCES INC 18 May 2022 1 $0 4 Director 20 May 2022, 16:14
NBIX NEUROCRINE BIOSCIENCES INC 01 Apr 2022 3 -$1.02M 4 Director 05 Apr 2022, 18:20
DARE Dare Bioscience, Inc. 24 Jun 2021 1 $0 4 Director 24 Jun 2021, 16:35
RGLS Regulus Therapeutics Inc. 14 Jun 2021 1 $0 4 Director 15 Jun 2021, 16:44
FATE FATE THERAPEUTICS INC 02 Jun 2021 2 $0 4 Director 04 Jun 2021, 17:30
NBIX NEUROCRINE BIOSCIENCES INC 19 May 2021 1 $0 4 Director 20 May 2021, 16:11